Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 59-2022

To publish the March 4, 2022 letter of the Food and Drug Administration endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
59
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 59-2022, issued April 27, 2022, publishes a March 4, 2022 letter from the Food and Drug Administration (OIC-Director General Dr. Oscar G. Gutierrez, Jr.) endorsing updates to the List of VAT-Exempt Medicines under RA No. 11534 (CREATE Act). The updated List now includes certain medicines for cancer and COVID-19 treatment. The provided text does not reproduce the actual list of medicines.